<i>In vivo</i> anti bacterial efficacy of <i>β-</i>lactam in <i>E</i>. <i>faecalis</i> infected mice.

Five mice in each group received three subcutaneous doses of β-lactams (25 and 50 mg/kg) and ampicillin (25 mg/kg) after 4 h of intravenous inoculation of E. faecalis. 120 h after infection and daily treatment with dose indicated, the kidney were harvested and CFU were measured in kidney. Non-parametric test was done for comparisons of significance for test versus control (p< 0.05). In vivo anti bacterial efficacy of β-lactam in E. faecalis infected mice.